Related Experiment Video
Updated: Sep 10, 2025
06:38
In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
Published on: March 7, 2025
619
Vertebrate and Invertebrate Animal Models for the Study of Down Syndrome
1Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
International Journal of Molecular Sciences
|August 28, 2025
Summary
Down syndrome (DS), a trisomy 21 condition, causes developmental delays and early-onset dementia. Animal models are crucial for understanding DS pathology and developing targeted therapies.
Area of Science:
- Genetics and Developmental Biology
- Neuroscience
- Animal Models of Human Disease
Background:
- Down syndrome (DS) is the most common survivable trisomy, affecting approximately 1 in 600-700 births.
- Individuals with DS experience developmental delays, congenital heart defects, skeletal issues, and Alzheimer's disease-type dementia later in life.
- Biological mechanisms underlying DS pathology remain incompletely understood.
Purpose of the Study:
- To review pertinent and well-studied animal models of Down syndrome.
- To discuss molecular pathways implicated in DS morbidity discovered through these models.
Main Methods:
- Review of existing literature on Down syndrome animal models.
- Focus on models in *C. elegans*, *Drosophila*, zebrafish, and mice.
- Analysis of molecular pathways identified in these models.
Main Results:
- Various animal models have been developed to study Down syndrome.
- These models have facilitated the discovery of molecular pathways contributing to DS-related developmental and age-related pathologies.
- Insights into Alzheimer's disease-type dementia in DS have been gained.
Conclusions:
- Animal models are essential tools for investigating the complex biological mechanisms of Down syndrome.
- Research using these models is advancing our understanding of DS morbidity and paving the way for therapeutic strategies.
